Viernes, 14 de Junio de 2019

08:30-09:00 h.

Entrega de documentación.

09:00-09:15 h.


Dr. Joan Colom.

09:15-10:00 h.

Symposium 1. Living positive: The effectiveness and implementation of a guided online intervention for people with HIV and depressive symptoms. 

Moderadores: Guida da Ponte – Andrea Calcagno.
Sanne Van Luenen – Vivian Kraaij.

10:00-10:45 h.

Symposium 2. A mobile app to screen for neurocognitive impairment HIV.

Moderadores: Scott Letendre – José A. Muñoz-Moreno.
Reuben Robbins.

10:45:11:30 h.



Understanding the role of patient reported outcomes in the management of HIV.
Moderadores: Jordi Blanch – Esteban Martínez.
Antonella Cingolani.

11:30-13:00 h.

Comunicaciones Orales. Sesión 1. 

Moderador: Esteban Martínez.

1.1 – Relevance of the QPC Cognitive complaints questionnaire as a guiding tool in the screening strategy for HIV‐associated neurocognitive disorders. 

Olivia Zaegel-Faucher.

1.2 – Resting EEG‐LORETA and CSF Biomarkers in Patients with HAND.

Alessandro Lazaro.

1.3 – Exploring the Association Between the Route of HIV Acquisition and the Different Patterns of Neurocognitive Impairment. 

Giulia de Zan.

1.4 – Remarkable Accuracy of the NEU Screen Detecting Cognitive Impairment in Aging People Living with HIV/AIDS.

José A Muñoz-Moreno.

1.5 – A Example of comprehensive neurocognitive assessment in a HIV population in Northern Italy.

Cesare Bolla.

1.6 – No evidence of neuro‐axonal injury following latency reversal with vorinostat and HIV‐specific vaccination in the RIVER trial.

Jasmini Alagaratnam.

13:00-14:00 h.


14:00-14:45 h.

Symposium 3. Prevalence of mental health problems among people living with HIV. 

Moderadores: Amnemiek Schadé – Alan Winston.
Fiona Lampe.

14:45-17:45 h.

Workshops. Sesión sin traducción simultánea.
1. Substance use:

– Scope of the problem: Ignacio Pérez-Valero.
– Prevention: Milton Wainberg.
– Screening and diagnosis: Guida da Ponte.
– Treatment: Amnemiek Schadé.
Moderador: Jordi Blanch.

2. Neurocognitive diagnostic methods:

– Clinical diagnosis: when neurocognitive impairment should be suspected?. Scott Letendre.
– NP tests: which, when, and how?. José A. Muñoz-Moreno.
– Imaging: which procedures and how they can help?. Alan Winston. 
– What can we expect from biomarkers?. Paola Cinque.
– How to assess neurotoxicity?.  Andrea Calcagno.
Moderadores: Daniel Podzamczer y Esteban Martínez.

Presentación de 10-15 min. para cada tema y 45-60 min. de discusión con preguntas acerca de “screening”, diagnóstico, prevención y tratamiento.

Sábado, 15 de Junio de 2019

09:00-10:00 h.

Case Studies.

Moderador: Alan Winston.
Brendan Payne – Monica Calado Marta – Jasmini Alagaratnam

10:00-10:30 h.


10:30-11:30 h.

Comunicaciones Orales. Sesión 2.

Moderador: Milton Wainberg.

2.1 – Retention in HIV care guidelines: Addressing comorbidity to achieve UNAIDS 90-90-90 targets.

Shiraze Bulsara.

2.2 – Psychological adjustment to Human Inmmunodeficiency Virus (HIV) and psychosocial associated factors.

Carmen Vicioso.

2.3 – A multidisciplinary approach between Consultation‐Liaison Psychiatry and HIV clinics in Portugal.

Guida da Ponte.

2.4 – HIV mental health care: a stepped care model to improve quality of life in people living with HIV.

Hendrik van Gorsel.

2.5 – Factors related to willingness to use PrEP among men who have sex with men from an HIV clinic in Mexico City.

Hamid Vega-Ramirez.

2.6 – Using Syndemic Theory to understand the ChemSex practice from the narratives of a group of gay and bisexual men in Barcelona city.

Percy Fernández Dávila.

11:30-12:15 h.

Symposium 4. Hot topics on CNS and HIV. 

Moderador: Esteban Martínez

Scott Letendre.


12:15-13:15 h.

Conferencia especial. New insights into the pathophysiology of major depressive disorder 

Moderador: Jordi Blanch
Francesc Artigas.  

13:15-13:30 h.

Clausura y despedida.

Descargar PDF del Programa

Ver Ponentes